Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Sebastian, S, Lambe, T
Natura:	Journal article
Pubblicazione:	MDPI 2018

Documenti analoghi

Clinical Advances in Viral-Vectored Influenza Vaccines
di: Sarah Sebastian, et al.
Pubblicazione: (2018-05-01)

Viral vector vaccines
di: McCann, N, et al.
Pubblicazione: (2022)

Clinical development of viral vectored vaccines against MERS-COV
di: Ewer, K, et al.
Pubblicazione: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
di: D. A. Mezhenskaia, et al.
Pubblicazione: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
di: Bissett, C, et al.
Pubblicazione: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
di: Ewer (nee Russell), K, et al.
Pubblicazione: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
di: Cameron Bissett, et al.
Pubblicazione: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
di: Arunkumar, G, et al.
Pubblicazione: (2019)

Research advances in replication-deficient viral vector vaccines
di: Junna Wang, et al.
Pubblicazione: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
di: McMahon, M, et al.
Pubblicazione: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
di: Antrobus, R
Pubblicazione: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
di: Tully, C, et al.
Pubblicazione: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
di: Tully, C
Pubblicazione: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
di: Mullin, J, et al.
Pubblicazione: (2014)

Development of viral vectors for passive immunisation against influenza
di: Tan, TK
Pubblicazione: (2017)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
di: Marta Ulaszewska, et al.
Pubblicazione: (2023-01-01)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
di: Irina Isakova-Sivak, et al.
Pubblicazione: (2022-07-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
di: Antrobus, R, et al.
Pubblicazione: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
di: Antrobus, R, et al.
Pubblicazione: (2014)

Adenoviral vectors as novel vaccines for influenza.
di: Coughlan, L, et al.
Pubblicazione: (2015)

Virus-Vectored Influenza Virus Vaccines
di: Ralph A. Tripp, et al.
Pubblicazione: (2014-08-01)

Viral vectors for malaria vaccine development.
di: Li, S, et al.
Pubblicazione: (2007)

The use of viral vectors in vaccine development
di: Tatianna Travieso, et al.
Pubblicazione: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
di: Kenneth Lundstrom
Pubblicazione: (2016-11-01)

Developments in Viral Vector-Based Vaccines
di: Takehiro Ura, et al.
Pubblicazione: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
di: Ewer (nee Russell), K, et al.
Pubblicazione: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
di: Kapulu, MC
Pubblicazione: (2014)

Recombinant influenza A viruses as vaccine vectors
di: Thomas Gerlach, et al.
Pubblicazione: (2019-04-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
di: Katie Ewer, et al.
Pubblicazione: (2017-12-01)

Viral vectors as vaccine platforms: Deployment in sight
di: Rollier, C, et al.
Pubblicazione: (2011)

Novel viral vector vaccines for tropical infections
di: Rampling, T
Pubblicazione: (2017)

Viral vectors as vaccine platforms: deployment in sight.
di: Rollier, C, et al.
Pubblicazione: (2011)

Viral Vectors for COVID-19 Vaccine Development
di: Kenneth Lundstrom
Pubblicazione: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
di: Luis Jiménez-Cabello, et al.
Pubblicazione: (2020-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
di: Sushmita Kumari, et al.
Pubblicazione: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
di: Jianfeng Zhang
Pubblicazione: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
di: Shintaro Shichinohe, et al.
Pubblicazione: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
di: L. M. Khantimirova, et al.
Pubblicazione: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
di: McAuliffe, J
Pubblicazione: (2020)

Baculovirus expression vector system for production of viral vaccines /
di: 300419 Vlak, J. M., et al.